Third dose of the BNT162b2 vaccine in cardiothoracic transplant recipients: predictive factors for humoral response

BACKGROUND: We report the results of a prospective study on the immunogenicity of a 3rd dose of BNT162b2 in thoracic organ recipients with no or minimal response following a two-dose BNT162b2 vaccination scheme. METHODS: A total of 243 transplant recipients received a homologue 3rd dose. Anti-SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Costard-Jäckle, Angelika, Schramm, René, Fischer, Bastian, Rivinius, Rasmus, Bruno, Raphael, Müller, Benjamin, Zittermann, Armin, Boeken, Udo, Westenfeld, Ralf, Knabbe, Cornelius, Gummert, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395841/
https://www.ncbi.nlm.nih.gov/pubmed/35994091
http://dx.doi.org/10.1007/s00392-022-02075-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395841/
https://www.ncbi.nlm.nih.gov/pubmed/35994091
http://dx.doi.org/10.1007/s00392-022-02075-2

Ejemplares similares